Total Payments
$4,813
2024 Payments
$600.36
Companies
31
Transactions
295
Medicare Patients
9,420
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$4,758 (98.9%)
Education$55.02 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,758 | 294 | 98.9% |
| Education | $55.02 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $1,177 | 76 | $0 (2024) |
| PFIZER INC. | $575.84 | 43 | $0 (2019) |
| Abbott Laboratories | $447.99 | 27 | $0 (2021) |
| Nevro Corp. | $398.79 | 6 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $242.49 | 20 | $0 (2021) |
| Zyla Life Sciences | $233.87 | 27 | $0 (2019) |
| Egalet US Inc | $232.45 | 17 | $0 (2018) |
| Purdue Pharma L.P. | $231.55 | 11 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $158.64 | 10 | $0 (2018) |
| ABBVIE INC. | $144.94 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $600.36 | 20 | Nevro Corp. ($351.34) |
| 2023 | $58.83 | 3 | Collegium Pharmaceutical, Inc. ($44.82) |
| 2022 | $422.51 | 19 | Collegium Pharmaceutical, Inc. ($119.65) |
| 2021 | $367.63 | 18 | Collegium Pharmaceutical, Inc. ($160.05) |
| 2020 | $538.15 | 36 | Abbott Laboratories ($273.22) |
| 2019 | $816.78 | 64 | Zyla Life Sciences ($233.87) |
| 2018 | $1,284 | 89 | Collegium Pharmaceutical, Inc. ($357.98) |
| 2017 | $724.68 | 46 | Purdue Pharma L.P. ($217.91) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Opioid Analgesic | ||||||
| 10/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.44 | General |
| Category: Opioid Analgesic | ||||||
| 10/24/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $4.14 | General |
| Category: Opioid Analgesic | ||||||
| 09/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $12.21 | General |
| Category: Opioid Analgesic | ||||||
| 08/21/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $70.90 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/20/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart, Flector | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Endocrinology | ||||||
| 08/13/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.70 | General |
| Category: Opioid Analgesic | ||||||
| 07/25/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $138.94 | General |
| Category: Spinal Cord Stimulator | ||||||
| 07/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $10.14 | General |
| Category: Opioid Analgesic | ||||||
| 06/03/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.08 | General |
| Category: Opioid Analgesic | ||||||
| 04/29/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.05 | General |
| Category: Opioid Analgesic | ||||||
| 04/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $4.72 | General |
| Category: Opioid Analgesic | ||||||
| 04/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.27 | General |
| Category: Opioid Analgesic | ||||||
| 03/27/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $141.50 | General |
| Category: Spinal Cord Stimulator | ||||||
| 02/27/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $5.20 | General |
| Category: Opioid Analgesic | ||||||
| 02/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $5.86 | General |
| Category: Opioid Analgesic | ||||||
| 02/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: Opioid Analgesic | ||||||
| 01/08/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $9.76 | General |
| Category: Opioid Analgesic | ||||||
| 07/26/2023 | Kowa Pharmaceuticals America, Inc. | SEGLENTIS (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: PAIN MANAGEMENT | ||||||
| 06/21/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Opioid Analgesic | ||||||
| 01/04/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Opioid Analgesic | ||||||
| 12/05/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: Opioid Analgesic | ||||||
| 10/26/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,421 | 4,593 | $2.2M | $303,344 |
| 2022 | 25 | 2,269 | 4,532 | $2.0M | $279,738 |
| 2021 | 26 | 2,557 | 3,705 | $2.4M | $343,588 |
| 2020 | 25 | 2,173 | 3,083 | $2.0M | $252,504 |
Total Patients
9,420
Total Services
15,913
Medicare Billing
$1.2M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 468 | 839 | $529,433 | $81,072 | 15.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 216 | 290 | $135,716 | $44,503 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 334 | 458 | $196,497 | $29,068 | 14.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 87 | 125 | $187,821 | $25,735 | 13.7% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 86 | 124 | $93,080 | $13,338 | 14.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 64 | 78 | $94,127 | $12,831 | 13.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 100 | 100 | $97,868 | $12,813 | 13.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 40 | 48 | $70,704 | $9,513 | 13.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 54 | 78 | $115,995 | $8,210 | 7.1% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 30 | 39 | $62,636 | $8,065 | 12.9% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 63 | 64 | $19,582 | $7,177 | 36.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 51 | 59 | $98,877 | $6,264 | 6.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 59 | 67 | $97,349 | $5,387 | 5.5% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 20 | 22 | $36,454 | $4,427 | 12.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 51 | 73 | $54,032 | $4,335 | 8.0% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 30 | 39 | $30,825 | $4,286 | 13.9% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 20 | 20 | $31,526 | $4,032 | 12.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 24 | 32 | $51,295 | $3,925 | 7.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $22,921 | $2,945 | 12.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 40 | 48 | $39,894 | $2,320 | 5.8% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Facility | 2023 | 23 | 30 | $24,119 | $2,136 | 8.9% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 15 | 17 | $9,825 | $1,599 | 16.3% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Facility | 2023 | 17 | 18 | $28,983 | $1,581 | 5.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 23 | 26 | $11,490 | $1,481 | 12.9% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 15 | 15 | $11,346 | $1,409 | 12.4% |
About Dr. Ramon Alvarez, MD
Dr. Ramon Alvarez, MD is a Anesthesiology healthcare provider based in Palm Beach Gardens, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063450310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramon Alvarez, MD has received a total of $4,813 in payments from pharmaceutical and medical device companies, with $600.36 received in 2024. These payments were reported across 295 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,758).
As a Medicare-enrolled provider, Alvarez has provided services to 9,420 Medicare beneficiaries, totaling 15,913 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Location Palm Beach Gardens, FL
- Active Since 06/02/2006
- Last Updated 12/21/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1063450310
Products in Payments
- XTAMPZA (Drug) $851.22
- LYRICA (Drug) $537.16
- Senza (Device) $351.34
- Proclaim Family of SCS IPGs (Device) $329.76
- SPRIX (Drug) $244.33
- Xtampza ER (Drug) $200.00
- BUNAVAIL 2.1 mg 30-count box (Drug) $195.99
- MOVANTIK (Drug) $158.64
- HYSINGLA ER (Drug) $147.13
- ZORVOLEX (Drug) $133.70
- BOTOX (Biological) $102.53
- Proclaim IPG (Device) $97.85
- Morphabond ER (Drug) $88.94
- Belbuca (Drug) $81.53
- Horizant (Drug) $80.13
- ARYMO ER (Drug) $74.61
- Superion Indirect Decompression System (Device) $69.46
- QULIPTA (Drug) $54.84
- AMRIX (Drug) $53.28
- ZOHYDRO ER (Drug) $52.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Palm Beach Gardens
Edwin Maldonado, Md, MD
Anesthesiology — Payments: $25,883
Anesthesiology $25,883
Lawrence Kirschenbaum, M.d, M.D
Anesthesiology — Payments: $4,496
Anesthesiology $4,496
Chin Chen, Md, MD
Anesthesiology — Payments: $3,104
Anesthesiology $3,104
Dragica Newton, Md, MD
Anesthesiology — Payments: $2,458
Anesthesiology $2,458
E. Michael Tarazi, M.d, M.D
Anesthesiology — Payments: $424.76
Anesthesiology $424.76
Atanaska Pirintchieva, M.d, M.D
Anesthesiology — Payments: $322.26
Anesthesiology $322.26